This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Neil Barnwell: Innovator in Anti-Arrhythmic Compounds
Introduction
Neil Barnwell is a notable inventor based in Leichestershire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-arrhythmic compounds. His work is crucial for advancing treatments for cardiac arrhythmias.
Latest Patents
Neil Barnwell holds a patent for "3,7-Diazabicyclo [3.3.1] formulations as anti-arrhythmic compounds." This patent includes substantially crystalline forms of various compounds that are useful in treating cardiac arrhythmias. The compounds include 4-({3-[7-(3,3-dimethyl-2-oxobutyl)-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl]propyl}amino)benzo-nitrile and several tert-butyl derivatives, along with their pharmaceutically-acceptable salts.
Career Highlights
Neil Barnwell is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on innovative solutions for complex health issues, particularly in cardiology.
Collaborations
Neil has collaborated with esteemed colleagues such as Annika Björe and Karin Lövqvist. These partnerships have enhanced the research and development of effective pharmaceutical solutions.
Conclusion
Neil Barnwell's contributions to the field of anti-arrhythmic compounds highlight his innovative spirit and dedication to improving cardiac health. His patent and work at AstraZeneca reflect his commitment to advancing medical science.